press-release

MJardin Announces the Acquisition of Cannabella - Acquisition Adds Extraction Capabilities and Consumer Products to the Company’s Nevada Portfolio

DENVER, Colorado, and TORONTO, Canada, April 22, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in cannabis production, announced today that it has entered into a definitive agreement (the “Transaction”) to acquire Carson City Agency Solutions, dba Cannabella, an operator of an extraction facility and producer of edibles and topicals in Carson City, Nevada.

MJardin’s Atlantic Canada Facility Reaches Full Production Capacity in 4 Months

Nova Scotia Mi’kmaq First Nations, Halef Group, and MJardin Expect Sales License this Spring

TORONTO, Canada and DENVER, Colorado, April 18, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), is pleased to announce that its joint-venture AtlantiCann Medical Inc. (“AMI”) facility located in Lower Sackville, Nova Scotia has now reached its full production capacity in an impressive four months since receiving its cultivation and processing license on December 7, 2018.  AMI is a three-way joint-venture consisting of Nova Scotia Mi’kmaq First Nations (51%), MJardin Group, Inc. (39%) and the Halef Group (10%).

MJardin Announces Nova Scotia Mi’kmaq First Nations Joining its AMI Partnership

 

TORONTO, Canada and DENVER, Colorado, April 1, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in cannabis production, is pleased to announce the completion of an Agreement (the “Agreement”), whereby the Nova Scotia Mi’kmaq First Nations (“Mi’kmaq”) will own a 51% stake in AtlantiCann Medical Inc. (“AMI”). As a result of the Agreement, MJardin and the Halef Group will own 39% and 10% of AMI, respectively. In connection with the partnership formed under the Agreement, MJardin, the Mi’kmaq and the Halef Group are contemplating expansion of their relationship, including retail.

MJardin Group Commences Trading on OTCQX Best Market

DENVER, January 15, 2019 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR) (OTCQX: MJARF), a global leader in cannabis management, announced today that its common stock has been approved to upgrade to the OTCQX Best Market, effective immediately.

MJARDIN GROUP, INC. ANNOUNCES FILING OF 2018 ANNUAL FINANCIAL STATEMENTS OF SUMTRA DIVERSIFIED INC.

DENVER, January 14, 2019 – MJardin Group, Inc. ("MJardin" or the "Company") (CSE: MJAR), a multi-country leader in cannabis management, announced today that the Company has filed Sumtra Diversified Inc.’s audited annual financial statements for the period ending August 31, 2018.

MJardin Group Announces Definitive Agreement for Joint Venture with Rama First Nation

DENVER, January 10, 2019 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, announced today that it has completed a definitive agreement for its previously announced joint venture with Rama First Nation to bring large-scale cannabis cultivation, extraction, and retail to Rama, Ontario and the surrounding region. The partnership’s first major project will be the construction of a large-scale cannabis production facility which will create at least 100 permanent jobs for Rama and area residents.  

MJardin Group Issues CEO Letter to Company Stakeholders

DENVER, January 8, 2019 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today issued a letter to stakeholders from Rishi Gautam, Chairman and Chief Executive Officer, to provide an update on the Company’s business and growth strategy.  The letter can be found on the Company’s Investor Relations site and below.

MJardin Group Receives Its First Cannabis Sales License from Health Canada

DENVER – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced that its WILL cultivation facility in Brampton, Ontario has received its first license to sell cannabis under the Cannabis Act (Canada), which went into effect on October 17, 2018.

MJardin Group Added to the CSE Composite Index

DENVER, Colorado – December 24, 2018 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced that the Company has been added to the CSE Composite Index, effective at the market close Friday, December 21, 2018.

MJardin Group Announces Medical Cannabis Research Investment in Spain

Collaboration with Salamanca University and the Institute of Neuroscience of Castilla y León to Study the Benefits of Cannabinoids on Epilepsy and Schizophrenia.

DENVER, December 18, 2018 – MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced its first medical cannabis research investment to fund two studies on the benefits of cannabinoids on epilepsy and schizophrenia.